Abstract Number: 1276 • ACR/ARP Annual Meeting 2019
Myositis Specific Antibodies and Clinical Features in Patients from Argentina
Background/Purpose: To know the frequency of myositis specific antibodies (MSAs) and myositis associated antibodies( MAAs) and their relation with clinical features in patients with idiopathic…Abstract Number: 851 • ACR/ARHP Annual Meeting 2017
Autoantibodies Predict Long Term Survival in Myositis Associated Interstitial Lung Disease
Background/Purpose: Interstitial lung disease (ILD) significantly contributes to morbidity and mortality in adult polymyositis (PM) and dermatomyositis (DM). Myositis associated autoantibodies (MAA) are associated with…Abstract Number: 289 • ACR/ARHP Annual Meeting 2015
Evaluation of Usefulness of Krebs Von Den Lungen-6 As a Biomarker of Interstitial Lung Disease with Polymyositis and Dermatomyositis Including in the Short Time Course after Treatment
Background/Purpose: Because of the extremely variable incidence and outcome of interstitial lung disease (ILD) in polymyositis/dermatomyositis (PM/DM), explorationand validation of biomarkers for diagnosis, prognosis, and response…
ACR Meeting Abstracts